Immunophenotypic and DNA Genotypic Analysis of T-Cell and NK-Cell Subpopulations in Patients with B-Cell Chronic Lymphocytic Leukaemia (B-CLL)

References

• Catovsky D., Milliani E., Okos A., Galton D. Clinical significance of T cells in chronic lymphocytic leukaemia. Lancet 1974; 2: 751
   PubMed Web of Science ®Google Scholar
• Kay N. E., Johnson J. D., Stanek R., Douglas S. D. T-cell subpopulations in chronic lymphocytic leukaemia: Abnormalities in distribution and in vitro maturation. Blood 1979; 54: 540
   PubMed Web of Science ®Google Scholar
• Gale R. F., Foon K. A. Biology of chronic lymphocytic leukaemia. Semin. Haematol. 1987; 24: 209–229
   PubMed Web of Science ®Google Scholar
• Totterman T. H., Carlsson M., Simonsson B., Bengtsson M., Nilsson K. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 1989; 74: 786–792
   PubMed Web of Science ®Google Scholar
• MacKenzie R. H., Sewell H., Dawson A. A., Ratcliff M. A., Bennett N. B., King D. J. Immunoregulatory T cells in B cell chronic lymphocytic leukaemia: Evidence of a unique phenotype; a flow cytometry study. Disease Markers 1990; 8: 137–143
   PubMed Web of Science ®Google Scholar
• Crockard A. D., Alexander H. D., Stephenson C. F., McCrea P., Desai Z. R., Morris T. C. M., McNeill T. A. An analysis of circulating CD4 lymphocyte sub-populations in B-cell chronic lymphocytic leukaemia. Leukemia and Lymphoma 1990; 3: 127–133
   PubMed Web of Science ®Google Scholar
• Morimoto C., Letvin N. L., Distaso J. A., Brown H. M., Schlossman S. F. The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur. J. Immunol. 1986; 16: 198–204
   PubMed Web of Science ®Google Scholar
• Akbar A. N., Terry L., Timms A., Beverley P. C. L., Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 1988; 140: 2171–2178
   PubMed Web of Science ®Google Scholar
• Clement L. T., Yamashita N., Martin A. M. The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J. Immunol. 1988; 141: 1464–1470
   PubMed Web of Science ®Google Scholar
• Nesbitt A. M., Jones D. B., Moore K. Pheno-typic changes in a CD4+ lymphocyte subset correlate with a conversion from suppressor to helper inducer function. Immunology 1990; 69: 65–70
   PubMed Web of Science ®Google Scholar
• Wallace D. L., Beverley P. C. L. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990; 69: 460–467
   PubMed Web of Science ®Google Scholar
• Byrne J. A., Butler J. L., Cooper M. D. Differential activation requirement for virgin and memory T cells. J. Immunol. 1988; 141: 3249
   PubMed Web of Science ®Google Scholar
• Serra H. M., Mant M. J., Ruether B. A., Ledbetter J. A., Pilarsky L. M. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients. J. Clin. Immunol. 1988; 8: 259–265
   PubMed Web of Science ®Google Scholar
• Akbar A. N., Timms A., Janossy G. Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology 1989; 66: 213–218
   PubMed Web of Science ®Google Scholar
• Richards S. J., Scott C. S. Immunophenotypic dissection of normal peripheral blood NK associated (NKa) subpopulations by flow cytometry: Morphological features and relationships between membrane NKa (CD11b, CD16, CD56 and CD57) and T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) associated determinant expression. Leukemia and Lymphoma 1990; 2: 111–126
   PubMedGoogle Scholar
• Richards S. J., Jones R. A., Roberts B. E., Patel D., Scott C. S. Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes. Clin. Exp. Immunol. 1990; 81: 149–155
   PubMed Web of Science ®Google Scholar
• Hamblin T. J., Oscier D. G., Young B. J. Autoimmunity in chronic lymphocytic leukaemia. J. Clin. Pathol. 1986; 39: 713–716
   PubMed Web of Science ®Google Scholar
• Kay N. E., Kaplan M. E. Defective T cell responsiveness in chronic lymphocytic leukemia: Analysis of activation events. Blood 1986; 67: 578–581
   PubMed Web of Science ®Google Scholar
• Kunicka J. E., Platsoucas C. D. Defective helper function of purified T4 cells and excessive suppressor activity of purified T8 cells in patients with B-cell chronic lymphocytic leukemia: T4 suppressor effector cells are present in certain patients. Blood 1988; 71: 1551–1560
   PubMed Web of Science ®Google Scholar
• Geisler C. H., Larsen J. K., Plesner T., Hansen M., Hansen M. M. Lack of prognostic significance of T lymphocyte subset counts in B-cell chronic lymphocytic leukaemia. Eur. J. Haematol. 1987; 38: 67–74
   PubMed Web of Science ®Google Scholar
• Yamashita N., Clement L. T. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes. J. Immunol. 1989; 143: 1518–1523
   PubMed Web of Science ®Google Scholar
• Bell E. B., Sparshott S. M. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990; 348: 163–166
   PubMed Web of Science ®Google Scholar
• Warren H. S., Skipsey L. J. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. Immunology 1991; 74: 78–85
   PubMed Web of Science ®Google Scholar
• Lightstone E. B., Wyllie D., Marvel J. In the mouse, the maturation stage of the peripheral CD4+CD45RA+ subset is different from that of the CD8+CD45RA+ subset. Eur. J. Immunol. 1991; 21: 2161–2165
   PubMed Web of Science ®Google Scholar
• Jones R. A., Richards S. J., Roberts B. E., Child J. A., Scott C. S. Phenotypic switch from CD45RA+ to CD45RA- by normal blood T cells is associated with increased HLA-ABC expression for CD4+ and CD8+ populations but not for the NK-associated CD4-CD8dim+ or CD4-CD8- fractions. Immunology 1990; 70: 55–60
   PubMed Web of Science ®Google Scholar
• Sanders M. E., Makgoba M. W., Shaw S. Human naive and memory T cells: Reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today 1988; 9: 195
   PubMedGoogle Scholar
• Peller S., Kaufman S. Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: Correlation with disease stage. Blood 1991; 78: 1569–1573
   PubMed Web of Science ®Google Scholar
• Briggs P. G., Kraft N., Atkins R. C. T cells and CD45R expression in B-chronic lymphocytic leukemia. Leuk. Res. 1990; 14: 155–159
   PubMed Web of Science ®Google Scholar
• Morimoto C., Halfer D., Weiner H. L., Letvin N. L., Hagan M., Daley J., Schlossman S. F. Selective loss of the suppressor-inducer T cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N. Engl. J. Med. 1987; 316: 67
   PubMed Web of Science ®Google Scholar
• Morimoto C., Stainberg A. D., Letvin N. L., Hagan M., Takeuchi T., Daley J., Levin H., Schlossman S. F. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J. Clin. Invest. 1987; 79: 762
   PubMed Web of Science ®Google Scholar
• Emery P., Gentry K. C., Mackay I. R., Muirden K. D., Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in Rheumatoid Arthritis. Arthritis Rheumatism 1987; 30: 849
   PubMed Web of Science ®Google Scholar
• Morimoto C., Romain P. L., Fox D. A., Anderson P., Dimaggio M., Levine H., Schlossman S. F. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory Rheumatic diseases. Am. J. Med. 1988; 84: 817
   PubMed Web of Science ®Google Scholar
• Takeuchi T., Tanaka S., Stainberg A. D., Matsuyama T., Daley J., Schlossman S. F., Morimoto C. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. J. Clin. Invest. 1988; 82: 1288
   PubMed Web of Science ®Google Scholar
• Karlsson F. A., Totterman T. H. Immunomod-ulation by methmazole therapy for Graves disease. Rapid changes in regulatory T cell subsets, activated B cells and NK cells. Clin. Exp. Immunol. 1988; 74: 258
   PubMedGoogle Scholar
• Jacob M.-C, Favre M., Lemarc'Hadour F., Sotto M.-F., Bonnefoix T., Sotto J.-J., Bensa J.-C. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell Non-Hodgkins lymphoma (NHL) or Hodgkins disease (HD). Am. J. Hematol. 1992; 39: 45–51
   PubMed Web of Science ®Google Scholar